On Tuesday, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) opened lower -1.26% from the last session, before settling in for the closing price of $31.76. Price fluctuations for TEVA have ranged from $12.47 to $33.42 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -9.65% annually for the last half of the decade. Company’s average yearly earnings per share was noted 5.63% at the time writing. With a float of $1.14 billion, this company’s outstanding shares have now reached $1.15 billion.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Teva- Pharmaceutical Industries Ltd. ADR is 0.16%, while institutional ownership is 57.51%. The most recent insider transaction that took place on Dec 16 ’25, was worth 371,504. In this transaction Chief Accounting Officer of this company sold 12,300 shares at a rate of $30.20, taking the stock ownership to the 5,650 shares. Before that another transaction happened on Dec 16 ’25, when Company’s Director sold 77,400 for $30.24, making the entire transaction worth $2,340,646. This insider now owns 367,600 shares in total.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.71 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.7) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.44% during the next five years compared to -9.65% drop over the previous five years of trading.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Check out the current performance indicators for Teva- Pharmaceutical Industries Ltd. ADR (TEVA). In the past quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.13. Likewise, its price to free cash flow for the trailing twelve months is 143.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.61, a number that is poised to hit 0.64 in the next quarter and is forecasted to reach 2.76 in one year’s time.
